Nitric oxide-donating aspirin inhibits the growth of pancreatic cancer cells through redox-dependent signaling

This publication has 28 references indexed in Scilit:

• SURGICAL MANAGEMENT OF CARCINOMA OF THE HEAD OF PANCREAS: EXTENDED LYMPHADENECTOMY OR MODIFIED EN BLOC RESECTION?
  Anz Journal of Surgery, 2008
• Induction of oxidative stress as a mechanism of action of chemopreventive agents against cancer
  British Journal of Cancer, 2008
• NO-donating aspirin inhibits the activation of NF-κB in human cancer cell lines and Min mice
  Carcinogenesis, 2008
• Canonical and Alternative MAPK Signaling
  Cell Cycle, 2007
• Nitric Oxide–Donating Aspirin Prevents Pancreatic Cancer in a Hamster Tumor Model
  Cancer Research, 2006
• Nitric Oxide-Donating Aspirin Inhibits Colon Cancer Cell Growth via Mitogen-Activated Protein Kinase Activation
  The Journal of Pharmacology and Experimental Therapeutics, 2006
• Cancer Prevention: A New Era beyond Cyclooxygenase-2
  The Journal of Pharmacology and Experimental Therapeutics, 2005
• Biochemical and cellular mechanisms of mammalian CDK inhibitors: a few unresolved issues
  Oncogene, 2005
• Cyclooxygenase-2 Overexpression Inhibits Platelet-derived Growth Factor-induced Mesangial Cell Proliferation through Induction of the Tumor Suppressor Gene p53 and the Cyclin-dependent Kinase Inhibitors p21waf-1/cip-1 and p27kip-1
  Journal of Biological Chemistry, 2002
• Evaluation of the probe 2',7'-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress
  Chemical Research in Toxicology, 1992